logo-loader
AIM:RENX OTC:RNLXY

Renalytix PLC

Receive alerts
Market:
AIM
Price
5.35 GBX
Day Change
-
Market Cap:
£35.87 m
52 weeks high
7.00
52 weeks low
1.60

In brief

Renalytix is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes.

The company has received FDA approval and Medicare reimbursement for kidneyintelX.dkd which is now offered commercially in the United States.